Value proposition

Providing objective diagnostic insights that enable better patient care

BrainScope is a medical neurotechnology company that is improving brain health by providing objective, diagnostic insights that enable better patient care. BrainScope is leading the way in the rapid and objective assessment of brain-related conditions, starting with mild traumatic brain injury (mTBI), utilizing multiple integrated assessment capabilities, artificial intelligence (AI), and digitization. The company’s technology supports the American College of Emergency Physicians (ACEP) Choosing Wisely® campaign to avoid CT scans of the head in emergency department patients with a minor head injury.

BrainScope’s innovative EEG-based, AI-derived algorithms empower physicians to quickly make accurate head injury assessments, addressing the full spectrum of traumatic brain injuries from structural (brain bleed) to functional (concussion) injuries, providing for the first time a full picture of the injury, and doing so in less time and without radiation. BrainScope enables clinicians to triage mTBI at the point of care without radiation and with a 31% demonstrated a potential reduction in unnecessary head CT Scans. The BrainScope device is the first and only FDA-cleared, objective, comprehensive, rapid, and radiation-free assessment of brain bleed and concussion.

Medical Devices, Traumatic Brain Injury, Concussions, and Biomarkers